Module

Adjuvant Treatment for Colon Cancer

Source: Research Priorities in Colorectal Cancer: Recommendations of the Scientific Leadership Council in GI Cancer of the Coalition of Cancer Cooperative Groups

Adjuvant Treatment for Colon Cancer

Faculty:

Richard M. Goldberg, MD

CME CREDIT INFORMATION

Release Date: 09/06/07

Expiration Date: 09/05/08

Physicians: maximum of 0.5 AMA PRA Category 1 Credits™

Registered Nurses: 0.5 Nursing CE credits

Status: Please log in to view status

Learning Objectives

Upon completion of this activity, participants should be able to:

Discuss recommendations for or against the use of adjuvant chemotherapy for patients with stage II colon cancer
Describe current clinical trial data regarding adjuvant chemotherapy for patients with advanced colon cancer
Summarize upcoming clinical trials of targeted therapies for the adjuvant treatment of colon cancer

Topics covered include:

Disease Staging
Adjuvant Therapy and Survival
Other Adjuvant Therapy Trials
Capecitabine in Colon Cancer
Chemotherapy Plus Targeted Therapies
Priority Issues in Colorectal Cancer: Adjuvant Treatment for Colon Cancer

Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.